Do analysts recommend VTIX or AIMD?

Virtuix currently has a consensus price target of $11.00, indicating a potential upside of 1,055.46%. Given Virtuix's stronger consensus rating and higher probable upside, research analysts clearly believe Virtuix is more favorable than Ainos. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virtuix 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, VTIX or AIMD?

Ainos has lower revenue, but higher earnings than Virtuix. Virtuix is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Virtuix $3.99M 7.15 -$16.80M -$0.70 N/A Ainos $120K 84.56 -$14.77M -$2.52 N/A

Is VTIX or AIMD more profitable?

Virtuix has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Virtuix's return on equity of 0.00% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Virtuix N/A N/A N/A Ainos -11,912.10% -217.50% -67.87%

Does the media favor VTIX or AIMD?

In the previous week, Virtuix had 2 more articles in the media than Ainos. MarketBeat recorded 6 mentions for Virtuix and 4 mentions for Ainos. Virtuix's average media sentiment score of 0.99 beat Ainos' score of 0.62 indicating that Virtuix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Virtuix 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ainos 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AIMD or FOXX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Foxx Development 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, AIMD or FOXX?

Foxx Development has higher revenue and earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than Foxx Development, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $120K 84.56 -$14.77M -$2.52 N/A Foxx Development $59.54M 0.30 -$9.02M -$6.87 N/A

Is AIMD or FOXX more profitable?

Foxx Development has a net margin of -79.80% compared to Ainos' net margin of -11,912.10%. Foxx Development's return on equity of 0.00% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Ainos -11,912.10% -217.50% -67.87% Foxx Development -79.80% N/A -59.35%

Do analysts rate AIMD or EBON?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ebang International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, AIMD or EBON?

Ebang International has higher revenue and earnings than Ainos. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $120K 84.56 -$14.77M -$2.52 N/A Ebang International $6.88M 2.01 -$14.09M N/A N/A

Do analysts prefer AIMD or QCLS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mymd Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is AIMD or QCLS more profitable?

Mymd Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Mymd Pharmaceuticals' return on equity of -91.64% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Ainos -11,912.10% -217.50% -67.87% Mymd Pharmaceuticals N/A -91.64% -47.48%

Does the media prefer AIMD or QCLS?

In the previous week, Ainos had 1 more articles in the media than Mymd Pharmaceuticals. MarketBeat recorded 4 mentions for Ainos and 3 mentions for Mymd Pharmaceuticals. Mymd Pharmaceuticals' average media sentiment score of 0.93 beat Ainos' score of 0.62 indicating that Mymd Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ainos 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mymd Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BOXL or AIMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boxlight 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, BOXL or AIMD?

Ainos has lower revenue, but higher earnings than Boxlight. Ainos is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Boxlight $109.25M 0.03 -$23.81M -$80.86 N/A Ainos $120K 84.56 -$14.77M -$2.52 N/A

Is BOXL or AIMD more profitable?

Boxlight has a net margin of -20.96% compared to Ainos' net margin of -11,912.10%. Boxlight's return on equity of 0.00% beat Ainos' return on equity. Company Net Margins Return on Equity Return on Assets Boxlight -20.96% N/A -23.50% Ainos -11,912.10% -217.50% -67.87%

Does the media refer more to BOXL or AIMD?

In the previous week, Boxlight had 1 more articles in the media than Ainos. MarketBeat recorded 5 mentions for Boxlight and 4 mentions for Ainos. Boxlight's average media sentiment score of 0.77 beat Ainos' score of 0.62 indicating that Boxlight is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boxlight 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ainos 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Ainos (AIMD) Competitors

$1.38 +0.01 (+0.80%)

As of 01:36 PM Eastern

Compare

AIMD vs. VTIX, FOXX, EBON, QCLS, and BOXL

Should you buy Ainos stock or one of its competitors? Ainos's main competitors and comparable companies include Virtuix (VTIX), Foxx Development (FOXX), Ebang International (EBON), Mymd Pharmaceuticals (QCLS), and Boxlight (BOXL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does Ainos compare to Virtuix?

Virtuix (NASDAQ:VTIX) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Ainos has lower revenue, but higher earnings than Virtuix. Virtuix is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Virtuix	$3.99M	7.15	-$16.80M	-$0.70	N/A
Ainos	$120K	84.56	-$14.77M	-$2.52	N/A

In the previous week, Virtuix had 2 more articles in the media than Ainos. MarketBeat recorded 6 mentions for Virtuix and 4 mentions for Ainos. Virtuix's average media sentiment score of 0.99 beat Ainos' score of 0.62 indicating that Virtuix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Virtuix	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ainos	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Virtuix has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Virtuix's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Virtuix	N/A	N/A	N/A
Ainos	-11,912.10%	-217.50%	-67.87%

Virtuix currently has a consensus price target of $11.00, indicating a potential upside of 1,055.46%. Given Virtuix's stronger consensus rating and higher probable upside, research analysts clearly believe Virtuix is more favorable than Ainos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Virtuix	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Virtuix beats Ainos on 10 of the 13 factors compared between the two stocks.

How does Ainos compare to Foxx Development?

Ainos (NASDAQ:AIMD) and Foxx Development (NASDAQ:FOXX) are both small-cap technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Foxx Development has higher revenue and earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than Foxx Development, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$120K	84.56	-$14.77M	-$2.52	N/A
Foxx Development	$59.54M	0.30	-$9.02M	-$6.87	N/A

Foxx Development has a net margin of -79.80% compared to Ainos' net margin of -11,912.10%. Foxx Development's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	-11,912.10%	-217.50%	-67.87%
Foxx Development	-79.80%	N/A	-59.35%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Foxx Development	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ainos has a beta of 2.47, meaning that its share price is 147% more volatile than the broader market. Comparatively, Foxx Development has a beta of -0.35, meaning that its share price is 135% less volatile than the broader market.

60.4% of Foxx Development shares are owned by institutional investors. 9.8% of Ainos shares are owned by company insiders. Comparatively, 31.6% of Foxx Development shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Ainos had 3 more articles in the media than Foxx Development. MarketBeat recorded 4 mentions for Ainos and 1 mentions for Foxx Development. Foxx Development's average media sentiment score of 1.87 beat Ainos' score of 0.62 indicating that Foxx Development is being referred to more favorably in the news media.

Company	Overall Sentiment
Ainos	Positive
Foxx Development	Very Positive

Summary

Foxx Development beats Ainos on 9 of the 13 factors compared between the two stocks.

How does Ainos compare to Ebang International?

Ainos (NASDAQ:AIMD) and Ebang International (NASDAQ:EBON) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

In the previous week, Ainos had 3 more articles in the media than Ebang International. MarketBeat recorded 4 mentions for Ainos and 1 mentions for Ebang International. Ebang International's average media sentiment score of 1.87 beat Ainos' score of 0.62 indicating that Ebang International is being referred to more favorably in the news media.

Company	Overall Sentiment
Ainos	Positive
Ebang International	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ebang International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ebang International has higher revenue and earnings than Ainos.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$120K	84.56	-$14.77M	-$2.52	N/A
Ebang International	$6.88M	2.01	-$14.09M	N/A	N/A

Ebang International has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Ebang International's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	-11,912.10%	-217.50%	-67.87%
Ebang International	N/A	N/A	N/A

1.1% of Ebang International shares are held by institutional investors. 9.8% of Ainos shares are held by company insiders. Comparatively, 25.4% of Ebang International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ainos has a beta of 2.47, suggesting that its share price is 147% more volatile than the broader market. Comparatively, Ebang International has a beta of 2.99, suggesting that its share price is 199% more volatile than the broader market.

Summary

Ebang International beats Ainos on 9 of the 11 factors compared between the two stocks.

How does Ainos compare to Mymd Pharmaceuticals?

Ainos (NASDAQ:AIMD) and Mymd Pharmaceuticals (NASDAQ:QCLS) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

Mymd Pharmaceuticals has lower revenue, but higher earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than Mymd Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$120K	84.56	-$14.77M	-$2.52	N/A
Mymd Pharmaceuticals	N/A	N/A	-$11.63M	-$3.48	N/A

In the previous week, Ainos had 1 more articles in the media than Mymd Pharmaceuticals. MarketBeat recorded 4 mentions for Ainos and 3 mentions for Mymd Pharmaceuticals. Mymd Pharmaceuticals' average media sentiment score of 0.93 beat Ainos' score of 0.62 indicating that Mymd Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ainos	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mymd Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

9.6% of Mymd Pharmaceuticals shares are held by institutional investors. 9.8% of Ainos shares are held by insiders. Comparatively, 0.9% of Mymd Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mymd Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ainos has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market. Comparatively, Mymd Pharmaceuticals has a beta of 2.09, indicating that its stock price is 109% more volatile than the broader market.

Mymd Pharmaceuticals has a net margin of 0.00% compared to Ainos' net margin of -11,912.10%. Mymd Pharmaceuticals' return on equity of -91.64% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	-11,912.10%	-217.50%	-67.87%
Mymd Pharmaceuticals	N/A	-91.64%	-47.48%

Summary

Mymd Pharmaceuticals beats Ainos on 7 of the 12 factors compared between the two stocks.

How does Ainos compare to Boxlight?

Boxlight (NASDAQ:BOXL) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

In the previous week, Boxlight had 1 more articles in the media than Ainos. MarketBeat recorded 5 mentions for Boxlight and 4 mentions for Ainos. Boxlight's average media sentiment score of 0.77 beat Ainos' score of 0.62 indicating that Boxlight is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boxlight	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ainos	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Ainos has lower revenue, but higher earnings than Boxlight. Ainos is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boxlight	$109.25M	0.03	-$23.81M	-$80.86	N/A
Ainos	$120K	84.56	-$14.77M	-$2.52	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boxlight	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ainos	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Boxlight has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market. Comparatively, Ainos has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market.

Boxlight has a net margin of -20.96% compared to Ainos' net margin of -11,912.10%. Boxlight's return on equity of 0.00% beat Ainos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boxlight	-20.96%	N/A	-23.50%
Ainos	-11,912.10%	-217.50%	-67.87%

6.5% of Boxlight shares are held by institutional investors. 15.4% of Boxlight shares are held by insiders. Comparatively, 9.8% of Ainos shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Boxlight beats Ainos on 9 of the 13 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIMD vs. The Competition

Export

Metric	Ainos	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$10.15M	$115.31B	$29.28B	$14.40B
Dividend Yield	N/A	1.63%	2.73%	11.71%
P/E Ratio	-0.55	27.62	76.51	25.37
Price / Sales	84.56	97.01	585.84	98.88
Price / Cash	N/A	21.04	46.59	34.96
Price / Book	1.07	7.56	7.73	6.22
Net Income	-$14.77M	$3.49B	$705.00M	$358.05M
7 Day Performance	-7.09%	-6.32%	-1.52%	-1.30%
1 Month Performance	-3.17%	-8.52%	-4.43%	-3.33%
1 Year Performance	-59.44%	60.97%	176.69%	6.09%

Ainos Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIMD Ainos	0.6342 of 5 stars	$1.38 +0.4%	N/A	-61.5%	$10.15M	$120K	N/A	40	News Coverage Gap Up
VTIX Virtuix	2.3309 of 5 stars	$1.08 -5.7%	$11.00 +923.3%	N/A	$32.22M	$4.25M	N/A	39
FOXX Foxx Development	1.0057 of 5 stars	$2.56 -5.7%	N/A	-45.3%	$17.99M	$65.92M	N/A	N/A	Positive News Gap Down
EBON Ebang International	0.83 of 5 stars	$2.21 +1.9%	N/A	-53.0%	$14.46M	$6.54M	N/A	260	Positive News Gap Up
QCLS Mymd Pharmaceuticals	0.4318 of 5 stars	$1.71 -3.9%	N/A	N/A	$14.10M	N/A	N/A	6	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIMD) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ainos (AIMD) Competitors

AIMD vs. VTIX, FOXX, EBON, QCLS, and BOXL

How does Ainos compare to Virtuix?

Summary

How does Ainos compare to Foxx Development?

Summary

How does Ainos compare to Ebang International?

Summary

How does Ainos compare to Mymd Pharmaceuticals?

Summary

How does Ainos compare to Boxlight?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIMD vs. The Competition

Ainos Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ainos (AIMD) Competitors

AIMD vs. VTIX, FOXX, EBON, QCLS, and BOXL

How does Ainos compare to Virtuix?

Which has stronger earnings & valuation, VTIX or AIMD?

Does the media favor VTIX or AIMD?

Is VTIX or AIMD more profitable?

Do analysts recommend VTIX or AIMD?

Summary

How does Ainos compare to Foxx Development?

Which has stronger earnings and valuation, AIMD or FOXX?

Is AIMD or FOXX more profitable?

Do analysts prefer AIMD or FOXX?

Which has more volatility & risk, AIMD or FOXX?

Do insiders & institutionals hold more shares of AIMD or FOXX?

Does the media prefer AIMD or FOXX?

Summary

How does Ainos compare to Ebang International?

Does the media refer more to AIMD or EBON?

Do analysts rate AIMD or EBON?

Which has stronger valuation & earnings, AIMD or EBON?

Is AIMD or EBON more profitable?

Do institutionals and insiders believe in AIMD or EBON?

Which has more volatility & risk, AIMD or EBON?

Summary

How does Ainos compare to Mymd Pharmaceuticals?

Which has stronger earnings and valuation, AIMD or QCLS?

Does the media prefer AIMD or QCLS?

Do insiders & institutionals have more ownership in AIMD or QCLS?

Do analysts prefer AIMD or QCLS?

Which has more volatility & risk, AIMD or QCLS?

Is AIMD or QCLS more profitable?

Summary

How does Ainos compare to Boxlight?

Does the media refer more to BOXL or AIMD?

Which has preferable earnings and valuation, BOXL or AIMD?

Do analysts prefer BOXL or AIMD?

Which has more risk and volatility, BOXL or AIMD?

Is BOXL or AIMD more profitable?

Do institutionals & insiders hold more shares of BOXL or AIMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIMD vs. The Competition

Ainos Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools